Skip to main content
B-Cell Acute Lymphoblastic LeukaemiaCancer

What this study is

This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical \& Translational Science Institute.

Study details

Official title
Real World Outcomes of Blinatumomab Consolidation in Patients With B-cell Acute Lymphoblastic Leukemia
Sponsor
Medical College of Wisconsin
Conditions
B-Cell Acute Lymphoblastic Leukaemia
Enrolling
200 people
Starts
2025-08-28
Est. completion
2029-05-14
Record
View on ClinicalTrials.gov ↗